Ad Tech Compliance

    BAA or HIPAA authorization: what covers an ad platform that receives PHI?

    Published · Last updated

    Whether a business associate agreement (BAA) or a HIPAA authorization covers an ad platform depends on what the platform does with the data. A BAA governs a vendor that acts for the covered entity. An authorization can permit a disclosure to a recipient that acts for itself. Lawyers differ on platforms that do both.

    Contents

    Key facts

    • The definition looks at work done on behalf of a covered entity and services that involve protected health information. 45 CFR 160.103, business associate definition.
    • The rule calls for satisfactory assurances for business associate disclosures, documented in a written arrangement. 45 CFR 164.502(e)(1)–(2).
    • A business associate contract sets out uses, disclosures, safeguards and duties for the information it covers. 45 CFR 164.504(e)(2).
    • The marketing rule calls for authorization, with exceptions for face-to-face communications and gifts of nominal value. 45 CFR 164.508(a)(3).
    • Sale-related authorizations require a remuneration statement, and the rule specifies core elements for authorizations. 45 CFR 164.508(a)(4), (c).
    Jump to the table

    Definition

    Business associate agreement (BAA) means a written arrangement documenting the permitted uses, disclosures and safeguards for protected health information handled on a covered entity’s behalf.

    What the rule text says

    5 of 5 rows

    Columns (3)

    45 CFR 160.103, business associate definition

    The definition looks at work done on behalf of a covered entity and services that involve protected health information.

    45 CFR 164.502(e)(1)–(2)

    The rule calls for satisfactory assurances for business associate disclosures, documented in a written arrangement.

    45 CFR 164.504(e)(2)

    A business associate contract sets out uses, disclosures, safeguards and duties for the information it covers.

    45 CFR 164.508(a)(3)

    The marketing rule calls for authorization, with exceptions for face-to-face communications and gifts of nominal value.

    45 CFR 164.508(a)(4), (c)

    Sale-related authorizations require a remuneration statement, and the rule specifies core elements for authorizations.

    45 CFR 160.103, business associate definition

    What it says

    The definition looks at work done on behalf of a covered entity and services that involve protected health information.

    45 CFR 164.502(e)(1)–(2)

    What it says

    The rule calls for satisfactory assurances for business associate disclosures, documented in a written arrangement.

    45 CFR 164.504(e)(2)

    What it says

    A business associate contract sets out uses, disclosures, safeguards and duties for the information it covers.

    45 CFR 164.508(a)(3)

    What it says

    The marketing rule calls for authorization, with exceptions for face-to-face communications and gifts of nominal value.

    45 CFR 164.508(a)(4), (c)

    What it says

    Sale-related authorizations require a remuneration statement, and the rule specifies core elements for authorizations.

    Download JSON

    Table by this library, CC BY 4.0.

    The Health Insurance Portability and Accountability Act (HIPAA) rules distinguish the recipient’s functions from the form used to document a disclosure. Protected health information (PHI) is the starting point. A platform can receive different fields for delivery, reporting and its own research, and those uses warrant separate descriptions. The same company name can appear at several steps in the map. 45 CFR 160.103.

    The Department of Health and Human Services (HHS) explained in its 2013 final rule preamble that business associate status follows the definition. An executed contract documents the arrangement, while the work itself supplies facts for the classification. A business associate’s own uses of PHI are limited by the rule and its arrangement. 78 FR 5566, 5598; 45 CFR 164.502(a)(3).

    Two financial questions deserve their own entries in the map. One concerns remuneration from a third party for a marketing communication and the other concerns remuneration for the disclosure itself. The definitions and exceptions differ. The marketing definition excludes specified treatment, care coordination and own health-related service communications, subject to its remuneration terms. 45 CFR 164.501, marketing; 45 CFR 164.502(a)(5)(ii); 45 CFR 164.508(a)(3)–(4).

    The authorization rule asks for the information involved, the parties, purpose, expiry, signature and date. Its required statements address revocation, conditioning and possible redisclosure. Revocation is subject to the rule’s reliance and insurance exceptions. The rule generally limits conditioning treatment, payment, enrollment or benefit eligibility on signing, subject to specified exceptions. 45 CFR 164.508(b)(4)–(5), (c).

    Consider a health system hiring an outside service to report conversions. The work order might show that the system sets the goals and receives detailed reports. A second set of terms might say the recipient uses events to improve models used across clients. Counsel can assess the role for each activity and how the disclosure is documented.

    Where readings differ

    2 of 2 rows

    Columns (4)

    A cautious reading

    A platform that receives PHI while it delivers, optimises or measures the entity's campaign performs a function for the entity. It is a business associate for that function whether or not it signs. Without a BAA, PHI does not go to it. An authorization does not replace the BAA for that function.

    The functional definition in 160.103; 164.502(e); the HHS statement on status by definition

    PHI goes only to vendors under a BAA; other platforms receive data that is not PHI

    A permissive reading

    A patient may authorize a disclosure to a named recipient for the recipient's own use. A recipient that acts for itself is not a business associate for that use, so no BAA is needed for it. The authorization has to meet every element of 164.508.

    164.508(a) and (c); the definition's words "on behalf of"

    A documented authorization program names each platform and each use, with revocation handled end to end

    A cautious reading

    What it holds

    A platform that receives PHI while it delivers, optimises or measures the entity's campaign performs a function for the entity. It is a business associate for that function whether or not it signs. Without a BAA, PHI does not go to it. An authorization does not replace the BAA for that function.

    What it relies on

    The functional definition in 160.103; 164.502(e); the HHS statement on status by definition

    What it means for a design

    PHI goes only to vendors under a BAA; other platforms receive data that is not PHI

    A permissive reading

    What it holds

    A patient may authorize a disclosure to a named recipient for the recipient's own use. A recipient that acts for itself is not a business associate for that use, so no BAA is needed for it. The authorization has to meet every element of 164.508.

    What it relies on

    164.508(a) and (c); the definition's words "on behalf of"

    What it means for a design

    A documented authorization program names each platform and each use, with revocation handled end to end

    Download JSON

    Table by this library, CC BY 4.0.

    Where the readings collide. A platform can optimize a campaign for an entity while using events to improve services for other clients. Whether those are distinct functions depends on the actual terms, reports and data paths. The parties may also characterize the same payment or in-kind benefit differently under the remuneration provisions.

    Facts that change the answer

    • Who sets campaign parameters and approves changes?
    • Which reports or row-level data return to the covered entity?
    • Where do platform terms describe reuse for models or other advertisers?
    • Which payments or in-kind benefits are tied to the communication or disclosure?
    • What information, parties, uses and dates does the authorization describe?
    • Where is a revocation recorded, and how fast does it reach each recipient?
    • Which recipient terms limit the fields that can be sent?
    • Are the events on public pages, authenticated pages, or both?

    The same integration can have a payload for conversion delivery and a different payload for support logs. A capture of one successful request tells counsel little about a retry or a debug export. Keeping those examples separate helps show which recipient saw which fields and for what purpose.

    A dated form is useful alongside the actual interface and a revocation test. The form sets out the statement made to the individual. A record of the event and the recipient’s response shows how the system handles that statement in practice. These records can distinguish data sent before a revocation from attempts that occur after it.

    Payment records can separate a service fee from a benefit tied to access to the data. For example, a contract might price campaign reporting independently from a credit contingent on sending more events. Counsel can compare the contract to the invoice and use the rule’s definitions for each payment. An authorization record and a service record can refer to the same platform without covering the same activity. In an illustrative campaign, a system sends a conversion event for its own reporting and later lets the recipient combine events across customers. The reported fields and the recipient’s independent use belong on separate rows of the fact sheet.

    A team can also distinguish between a clause that describes allowed functions and the identity of the party actually performing them. A subcontractor might handle storage or report generation under different terms. The map can show the signed agreements beside the request chain so counsel can compare the stated service with the observed roles.

    That distinction gives counsel a record of both the agreement and the actual service.

    Questions to take to your counsel

    1. For each recipient in our flow, is it acting on our behalf or for itself, function by function?
    2. If a recipient does both, which of its functions need a BAA?
    3. Does our authorization form meet 45 CFR 164.508(c), and does it need the marketing or sale statements?
    4. Does any benefit we receive count as remuneration under the rule?
    5. How must a revocation reach each recipient, and how fast?
    6. Do the recipient's own terms forbid the data we plan to send, and what follows if they do?
    7. Which state laws apply to the same flow in addition to HIPAA?

    Bring the fact sheet from the counsel briefing kit so that counsel answers your flow, not a generic one.

    How business strategy and risk appetite enter

    A system can trade audience precision for simpler data boundaries or trade vendor choice for more control of a service. A choice-based program adds a separate workflow for forms, expiry and revocation. The business question is how much the added delivery or measurement is worth, given those operating costs and uncertainties.

    Changing the downstream vendor can also change the question even if the campaign looks the same to the patient. A buyer could switch to a different reporting provider or discover that the current one changed its model-training terms. The approval record can identify the specific functions and version of the data flow it addresses.

    3 of 3 rows

    Columns (4)

    Context and aggregate data without PHI sent to platforms

    Use page context or aggregate outcomes without sending patient-level records to a platform.

    The payload and reports still need classification.

    Delivery rules can change quickly, while past copies need separate handling.

    PHI limited to vendors under a BAA for the function

    Use campaign functions within a defined service relationship.

    The agreement, roles and actual downstream uses still matter.

    Replacing a vendor can require migration and contract closeout.

    Authorization-based program for named recipients

    Build a program around recorded choices and named recipients.

    Authorization terms, mixed functions and revocation need review.

    New sends can stop, but existing disclosures and reliance remain factual questions.

    Context and aggregate data without PHI sent to platforms

    What it gives the business

    Use page context or aggregate outcomes without sending patient-level records to a platform.

    What stays open

    The payload and reports still need classification.

    How hard it is to reverse

    Delivery rules can change quickly, while past copies need separate handling.

    PHI limited to vendors under a BAA for the function

    What it gives the business

    Use campaign functions within a defined service relationship.

    What stays open

    The agreement, roles and actual downstream uses still matter.

    How hard it is to reverse

    Replacing a vendor can require migration and contract closeout.

    Authorization-based program for named recipients

    What it gives the business

    Build a program around recorded choices and named recipients.

    What stays open

    Authorization terms, mixed functions and revocation need review.

    How hard it is to reverse

    New sends can stop, but existing disclosures and reliance remain factual questions.

    Download JSON

    Table by this library, CC BY 4.0.

    Which option fits is a business decision taken with counsel. It depends on how much the program is worth to you, how much uncertainty you accept and who signs for it.

    Status and recent developments

    On 20 June 2024 the Northern District of Texas vacated the portion of the HHS tracking guidance concerning a particular combination of an internet protocol address and a visit to an unauthenticated public page. The decision addressed the guidance’s treatment of that combination. It did not classify the actual fields in a separate campaign. American Hospital Association v. Becerra, No. 4:23-cv-1110-P, pp. 31–32, checked 10 November 2026.

    Related references

    FAQ

    Does an ad platform have to sign a BAA?
    The HIPAA definition turns on the platform’s function and the information involved. A platform that handles PHI on behalf of a covered entity raises different questions from a recipient using information only for itself. A contract and a payload capture can help describe the function that counsel is evaluating. 45 CFR 160.103; 45 CFR 164.502(e).
    Can a patient authorization replace a BAA?
    The two documents address different relationships. A business associate agreement describes permitted work on the entity’s behalf, while an authorization documents a specified use or disclosure. Where a recipient performs multiple functions, counsel can assess which instrument applies to each. 45 CFR 164.504(e); 45 CFR 164.508(c).
    Is a cookie banner a HIPAA authorization?
    The authorization rule lists core elements and required statements. A generic cookie banner normally records a storage or tracking choice, with different information and controls. The exact text, signature, date, purpose and recipients are among the facts to compare. 45 CFR 164.508(c)(1)–(2).
    What happens when a platform declines to sign a BAA?
    A refusal does not change the functional definition. The proposed payload, recipient role and terms become the focus. Context-based delivery and aggregate reporting have different inputs and outputs, and the treatment of a release can depend on what leaves the system. 45 CFR 160.103; 45 CFR 164.514.

    How this works on owned infrastructure

    When a health system controls its event intake, the system can keep form fields and patient-linked events on separate paths. It can capture the outbound request and show which report goes to which recipient. A dated data map can also distinguish the storage of raw events from the storage of totals.

    AdSovereign can run on infrastructure the organization controls. The team can show counsel where revocation is logged and how it affects each outbound integration. That changes the evidence available for the role and disclosure analysis. The architecture describes deployment boundaries that can be compared with the actual data flow.

    Sources

    1. 45 CFR 160.103, business associate definition. Checked 10 November 2026.
    2. 45 CFR 164.502(e)(1)–(2). Checked 10 November 2026.
    3. 45 CFR 164.504(e)(2). Checked 10 November 2026.
    4. 45 CFR 164.508(a)(3). Checked 10 November 2026.
    5. 45 CFR 164.508(a)(4), (c). Checked 10 November 2026.
    6. HHS, 2013 HIPAA Omnibus Final Rule, 78 FR 5598. Checked 10 November 2026.
    7. 45 CFR 164.501, definition of marketing. Checked 10 November 2026.
    8. 45 CFR 164.502(a)(3), (a)(5)(ii), uses and disclosures. Checked 10 November 2026.
    9. 45 CFR 164.514(a)–(c), de-identification. Checked 10 November 2026.
    10. N.D. Tex., American Hospital Association v. Becerra, No. 4:23-cv-1110-P, pp. 31–32. Checked 10 November 2026.
    Changelog
    • 10 November 2026: Published.